Myeloma 2017

Myeloma 2017

Targeting DNA methylation as a therapeutic target in multiple myeloma 0:47
Targeting DNA methylation as a therapeutic target in multiple myeloma
Benjamin Barwick
Genetic elements driving IMiD resistance in multiple myeloma 0:54
Genetic elements driving IMiD resistance in multiple myeloma
Benjamin Barwick
Analyzing genetic and epigenetic markers of high-risk multiple myeloma 2:16
Analyzing genetic and epigenetic markers of high-risk multiple myeloma
Benjamin Barwick
Exciting new developments in multiple myeloma 9:41
Exciting new developments in multiple myeloma
Daniel Auclair et al.
Utilizing combination therapies for multiple myeloma 1:11
Utilizing combination therapies for multiple myeloma
David Avigan
Novel therapeutics in multiple myeloma 13:23
Novel therapeutics in multiple myeloma
Christoph Driessen et al.
The future of immunotherapy in multiple myeloma 11:24
The future of immunotherapy in multiple myeloma
Hearn Cho et al.
Why use model systems for multiple myeloma research? 11:15
Why use model systems for multiple myeloma research?
Enrique Ocio et al.
The use of CAR T-cells in multiple myeloma 9:48
The use of CAR T-cells in multiple myeloma
Adam Cohen et al.
Multiple myeloma: genomic evolution 9:32
Multiple myeloma: genomic evolution
Jonathan Keats et al.
The exciting field of imaging in multiple myeloma 6:48
The exciting field of imaging in multiple myeloma
Jens Hillengass et al.
Where no man has gone before: the technologies being used to explore MM epigenetic factors 1:34
Where no man has gone before: the technologies being used to explore MM epigenetic factors
Felipe P. Cardoso
Myeloma 2017: an epigenetic research boom 2:35
Myeloma 2017: an epigenetic research boom
Felipe P. Cardoso
Detecting common mutations in MM patients through liquid biopsy 4:00
Detecting common mutations in MM patients through liquid biopsy
Suzanne Trudel
Liquid biospy approaches for detecting MM and their optimization 1:40
Liquid biospy approaches for detecting MM and their optimization
Suzanne Trudel
Liquid biopsies for multiple myeloma: the attractions and limits 3:33
Liquid biopsies for multiple myeloma: the attractions and limits
Jens Lohr
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals